SCHEMBL23204334

SCHEMBL23204334

CCOC(=O)c1c(OC)nc(SC)nc1-c1ccco1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 2/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ ALDH1A1 P00352 7/20 0.50
▸ PKM P14618 1/20 0.50
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ MAPT P10636 4/20 0.46
▸ TDP1 Q9NUW8 3/20 0.46
▸ ALOX15 P16050 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ POLB P06746 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPSR1 Q6W5P4 3/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ BLM P54132 2/20 0.46
▸ MCL1 Q07820 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ GAPDH P04406 1/20 0.46
▸ NR4A1 P22736 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21704463 0.88 L3MBTL1 (0.64) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL23162595 0.86 ADORA2B (0.57) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL29623173 0.86 ADORA2B (0.57) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL21704471 0.84 ADORA2B (0.58) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL21704319 0.79 L3MBTL1 (0.67) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL29623178 0.77 ADORA2B (0.57) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL23204450 0.77 ADORA2B (0.57) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL7147842 0.77 ADORA2B (0.57) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL29623513 0.77 ADORA2B (0.57) ADORA2BL3MBTL1ALDH1A1PKMMEN1
SCHEMBL23162622 0.75 ADORA2B (0.54) ADORA2BL3MBTL1ALDH1A1PKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021063852-A1 SUBSTITUTED PYRIMIDINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2021-04-08 — — WO disclosed
Send feedback